News

Press Releases
Back to Press Releases >
BIORESTORATIVE THERAPIES SIGNS LICENSE AGREEMENT WITH UNIVERSITY OF UTAH TO OBTAIN ADIPOSE (FAT) TISSUE FOR ITS THERMOSTEM PROGRAM TO TREAT OBESITY AND METABOLIC DISORDERS
08/25/2011
BIORESTORATIVE THERAPIES SIGNS LICENSE AGREEMENT WITH UNIVERSITY OF UTAH TO OBTAIN ADIPOSE (FAT) TISSUE FOR ITS THERMOSTEM PROGRAM TO TREAT OBESITY AND METABOLIC DISORDERS

JUPITER, FL, August 25, 2011 – BioRestorative Therapies, Inc. (OTCQB: SCLZ) (“BRT”) today announced that it has entered into a Tangible Property License Agreement with the University of Utah. The two year license agreement enables BioRestorative Therapies to obtain adipose (fat) tissue that will be used for research purposes to develop and commercialize its ThermoStem Program, which is an adult derived stem cell-based program to treat metabolic and obesity related disorders, using the thermogenic or heat producing properties of brown fat.

The agreement marks the beginning of a strategic collaboration between BRT and the University of Utah, an institution recognized as a leader in translational stem cell-based therapies. This relationship offers BRT an opportunity to procure adipose tissues from donors (tissue and cells that are usually difficult to obtain) to be used for BRT’s cellular research and characterization studies.

Dr. Amit Patel, Director of Clinical Regenerative Medicine and Tissue Engineering at the University of Utah and a member of the BRT Scientific Advisory Board, said, “Obesity is now the leading cause of preventable death and BRT’s ThermoStem Program is a novel cell-based approach to treat this disorder.”

Mark Weinreb, Chairman and CEO of BioRestorative Therapies, said, “We have been developing our ThermoStem Program to treat metabolic and obesity related disorders and the signing of this agreement with the University of Utah brings us closer to realizing clinical applications.”

BioRestorative Therapies: A Stem Cell Biotechnology Company